117 related articles for article (PubMed ID: 3115841)
1. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
Griffith RS; Walsh DE; Myrmel KH; Thompson RW; Behforooz A
Dermatologica; 1987; 175(4):183-90. PubMed ID: 3115841
[TBL] [Abstract][Full Text] [Related]
2. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
DiGiovanna JJ; Blank H
Arch Dermatol; 1984 Jan; 120(1):48-51. PubMed ID: 6419679
[TBL] [Abstract][Full Text] [Related]
3. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study.
Milman N; Scheibel J; Jessen O
Acta Derm Venereol; 1980; 60(1):85-7. PubMed ID: 6153847
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride.
McCune MA; Perry HO; Muller SA; O'Fallon WM
Cutis; 1984 Oct; 34(4):366-73. PubMed ID: 6435961
[TBL] [Abstract][Full Text] [Related]
5. Suppression of herpes simplex virus infections with oral lithium carbonate--a possible antiviral activity.
Amsterdam JD; Maislin G; Hooper MB
Pharmacotherapy; 1996; 16(6):1070-5. PubMed ID: 8947995
[TBL] [Abstract][Full Text] [Related]
6. Reduced rate of recurrent genital herpes infections with lithium carbonate.
Amsterdam JD; Maislin G; Potter L; Giuntoli R
Psychopharmacol Bull; 1990; 26(3):343-7. PubMed ID: 2125737
[TBL] [Abstract][Full Text] [Related]
7. Failure of oral inosiplex treatment of recurrent herpes simplex virus infections.
Kalimo KO; Joronen IA; Havu VK
Arch Dermatol; 1983 Jun; 119(6):463-7. PubMed ID: 6190441
[TBL] [Abstract][Full Text] [Related]
8. [Lysine prevention in recurrent labial herpes simplex].
Milman N; Scheibel J; Jessen O
Ugeskr Laeger; 1980 May; 142(19):1202-3. PubMed ID: 6773197
[No Abstract] [Full Text] [Related]
9. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
10. [Lysine therapy of recurrent herpes simplex labialis].
Milman N; Jessen O; Scheibel J
Ugeskr Laeger; 1979 Oct; 141(43):2960-2. PubMed ID: 392853
[No Abstract] [Full Text] [Related]
11. Failure of lysine in frequently recurrent herpes simplex infection.
Simon CA; Van Melle GD; Ramelet AA
Arch Dermatol; 1985 Feb; 121(2):167-8. PubMed ID: 3919651
[No Abstract] [Full Text] [Related]
12. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
13. Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation.
Hellgren L; Hermann LS
Dermatologica; 1983; 167(5):267-72. PubMed ID: 6360739
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
15. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
16. Dihydroergotamine in acute herpes simplex infections.
Steven ID
Med J Aust; 1987 Nov; 147(9):448-9. PubMed ID: 3312977
[TBL] [Abstract][Full Text] [Related]
17. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
19. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
20. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
